The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday.
Sep 17, 2023
0
14
Imagine a world where you could control your sense of time. Where trips to the dentist flew by in a second and holidays felt like they lasted forever. Time altering pills may sound like science fiction but the time warping ...
Aug 10, 2023
0
1
Psychedelic-based therapies are poised to change the treatments that psychiatrists can offer patients.
Jul 13, 2023
0
2
A new review in the journal Psychedelic Medicine describes the complex pharmacology of methylenedioxy amphetamine analogs, or MDXX drugs, and how they may help treat autism spectrum disorder (ASD).
Jun 29, 2023
0
1
Australia is the world's first country to legalize the medical use of psychedelics. But not everyone is sure the timing is right. There are still major issues to work out for this move to benefit those most in need.
May 1, 2023
0
19
Australia's drugs watchdog on Friday announced that psychedelic substances MDMA and psilocybin—more commonly known as ecstasy and magic mushrooms—will soon be used in the treatment of depression and post-traumatic stress.
Feb 3, 2023
0
24
Most eutylone-involved deaths in 2020 occurred in two states, and deaths commonly co-involved illicitly manufactured fentanyls (IMFs) and cocaine or methamphetamine, according to research published in the Aug. 12 issue of ...
Aug 12, 2022
0
2
A new study has highlighted the apparent effect of Brexit and the pandemic on the trade in the illegal party drug ecstasy (MDMA).
Jun 8, 2022
0
10
For people with post-traumatic stress disorder, recalling memories of physical or sexual assault, combat or disaster-related events can induce intense anxiety or panic attacks as well as debilitating flashbacks.
Dec 16, 2021
0
3
The Therapeutic Goods Administration (TGA) is considering rescheduling psilocybin and MDMA from their current classification as Schedule 9 prohibited substances to Schedule 8 controlled substances.
May 20, 2021
0
3
